← Alle mensen

TE

Taito Esaki

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab als eerste lijn bij gemetastaseerd CRC: fase II/III

European Journal of Cancer · 19 maart 2026

Health-related quality of life in patiënten met KRASG12C-mutated chemorefractory metastatic colorectal cancer treated...

The Lancet. Oncology · 2025-09

Totale overleving Analysis of the Fase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Ch...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-07

Sotorasib plus panitumumab bij KRAS G12C-gemuteerd refractair CRC: CodeBreaK 300 fase III

The New England journal of medicine · 7 december 2023

Panitumumab versus cetuximab plus irinotecan bij chemotherapierefractair KRAS-wildtype CRC: fase II

European journal of cancer (Oxford, England : 1990) · 2020-08

Trastuzumab beyond progression bij HER2-positief maagcarcinoom: fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juni 2020

S-1 plus leucovorin versus S-1/leucovorin/oxaliplatine versus S-1/cisplatine bij gevorderd maagcarcinoom

The Lancet. Oncology · 2016-01